Torax Medical carefully researches, develops and markets products designed to restore human sphincter function.
Torax Medical, based in the USA, was founded in 2002 with the mission of creating better treatment options for patients suffering from Gastro-Oesophageal Reflux Disease (GORD) and faecal incontinence (FI).
Through these efforts, Torax Medical has pioneered a new technology platform called Magnetic Sphincter Augmentation (MSA) designed to provide a permanent surgical solution to GORD and FI.
The LINX® Reflux Management System for the treatment of chronic GORD received CE Mark in 2008 and the FENIX® Continence Restoration System for the treatment of faecal incontinence received CE Mark in 2011.
Both the LINX® System and the FENIX® System are currently being used to treat patients in selected centres across Europe.